BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3729742)

  • 21. Clinical and pathological aspects of parkinsonism in Alzheimer's disease. A role for extranigral factors?
    Morris JC; Drazner M; Fulling K; Grant EA; Goldring J
    Arch Neurol; 1989 Jun; 46(6):651-7. PubMed ID: 2730377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease.
    Pappolla MA; Shank DL; Alzofon J; Dudley AW
    Hum Pathol; 1988 Jan; 19(1):27-31. PubMed ID: 2447008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An autopsy case of amyotrophic lateral sclerosis with concomitant Alzheimer's and incidental Lewy body diseases].
    Su M; Wakabayashi K; Tanno Y; Inuzuka T; Takahashi H
    No To Shinkei; 1996 Oct; 48(10):931-6. PubMed ID: 8921532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration?
    Perl DP; Olanow CW; Calne D
    Ann Neurol; 1998 Sep; 44(3 Suppl 1):S19-31. PubMed ID: 9749570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein E epsilon4 is associated with neuronal loss in the substantia nigra in Alzheimer's disease.
    Camicioli R; Kaye J; Payami H; Ball MJ; Murdoch G
    Dement Geriatr Cogn Disord; 1999; 10(6):437-41. PubMed ID: 10559556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down's syndrome and Parkinson's disease.
    Hestnes A; Daniel SE; Lees AJ; Brun A
    J Neurol Neurosurg Psychiatry; 1997 Mar; 62(3):289. PubMed ID: 9069490
    [No Abstract]   [Full Text] [Related]  

  • 27. Lewy bodies in the presence of Alzheimer's disease.
    Rosenblum WI; Ghatak NR
    Arch Neurol; 1979 Mar; 36(3):170-1. PubMed ID: 219817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathology of the substantia nigra in Alzheimer's disease.
    Reyes MG; Faraldi F; Chandran R; Verano A; Levi AC
    Panminerva Med; 1996 Mar; 38(1):8-14. PubMed ID: 8766873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [An 80-year-old woman with parkinsonism and progressive dementia].
    Hattori N; Sumino S; Takanashi M; Mori H; Wakiya M; Shirai T; Sugita H; Mizuno Y
    No To Shinkei; 1999 Jun; 51(6):541-50. PubMed ID: 10423759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dementia with Lewy bodies and Parkinson's disease with dementia: are they different?
    Tsuboi Y; Dickson DW
    Parkinsonism Relat Disord; 2005 Jun; 11 Suppl 1():S47-51. PubMed ID: 15885629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of Alzheimer-type pathology to dementia in Parkinson's disease.
    Jendroska K
    J Neural Transm Suppl; 1997; 49():23-31. PubMed ID: 9266411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lewy body disease.
    Hansen LA; Galasko D
    Curr Opin Neurol Neurosurg; 1992 Dec; 5(6):889-94. PubMed ID: 1467583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains.
    McGeer PL; Itagaki S; Boyes BE; McGeer EG
    Neurology; 1988 Aug; 38(8):1285-91. PubMed ID: 3399080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parkinson's disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)?
    Ling H; Kearney S; Yip HL; Silveira-Moriyama L; Revesz T; Holton JL; Strand C; Davey K; Mok KY; Polke JM; Lees AJ
    J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):633-41. PubMed ID: 26209716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
    Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
    Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alzheimer's disease with widespread presence of Lewy bodies.
    Mitsuyama Y; Fukunaga H; Yamashita M
    Folia Psychiatr Neurol Jpn; 1984; 38(1):81-8. PubMed ID: 6100367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Lewy-body variant of Alzheimer's disease. Clinical and pathological findings.
    Förstl H; Burns A; Luthert P; Cairns N; Levy R
    Br J Psychiatry; 1993 Mar; 162():385-92. PubMed ID: 8453435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review.
    Morra LF; Donovick PJ
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):569-76. PubMed ID: 24150834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The locus ceruleus and dementia in Parkinson's disease.
    Zweig RM; Cardillo JE; Cohen M; Giere S; Hedreen JC
    Neurology; 1993 May; 43(5):986-91. PubMed ID: 8492957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.